The effect of chronic dosing and p53 status on the genotoxicity of pro-oxidant chemicals in vitro.
Cell Line
Cells, Cultured
DNA Damage
/ drug effects
Drug Resistance
/ genetics
Glutathione
/ metabolism
Humans
Hydrogen Peroxide
/ administration & dosage
Micronucleus Tests
/ methods
Mutagenicity Tests
/ methods
Mutagens
/ administration & dosage
Oxidants
/ administration & dosage
Reactive Oxygen Species
/ metabolism
Tumor Suppressor Protein p53
/ deficiency
Vitamin K 3
/ metabolism
DNA damage
H2O2
KBrO3
Pro-oxidants
antioxidants
genotoxicity
glutathione
menadione
micronucleus (MN)
reactive oxygen species
Journal
Mutagenesis
ISSN: 1464-3804
Titre abrégé: Mutagenesis
Pays: England
ID NLM: 8707812
Informations de publication
Date de publication:
31 12 2020
31 12 2020
Historique:
received:
29
06
2020
accepted:
07
09
2020
pubmed:
2
12
2020
medline:
18
1
2022
entrez:
1
12
2020
Statut:
ppublish
Résumé
In this study, we have studied the cytotoxicity and genotoxic potency of 3 pro-oxidants; H2O2, menadione and KBrO3 in different dosing scenarios, namely acute (1-day dosing) and chronic (5-days). For this purpose, relative population doubling (RPD%) and mononucleated micronucleus (MN) test were used. TK6 cells and NH32 were employed in in vitro experiments. In the study, the total acute dose was divided into 5 days for each prooxidant chemicals by dose fractionation (1/5th per day) method. Acute dosing was compared to chronic dosing. The oxidative stress caused by the exposure of cells with pro-oxidant chemicals to the cells was determined by an optimized 2',7'-dichlorofluorescein diacetate (DCFHDA) test method. The antioxidant levels of the cell lines were altered with buthionine sulfoxide (BSO) and N-acetyl cysteine (NAC), and the effect of antioxidant capacity on the MN formation in the cells was observed with this method. In the case of H2O2 and menadione, fractional dosing has been observed to result in lower toxicity and lower genotoxicity. But in the case of KBrO3, unlike the other 2 pro-oxidants, higher MN induction was observed with fractionated doses. DCFHDA test clearly demonstrated ROS induction with H2O2 and menadione but not with KBrO3. Unexpectedly, DCFHDA test demonstrated that KBrO3 did not cause an increase ROS levels in both acute and chronic dosing, suggesting an alternative ROS induction mechanism. It was also observed that, treatment with BSO and NAC, caused increasing and decreasing of MN fold change respectively, allowing further ROS specific mechanisms to be explored. Hence, dose fractionation expectedly caused less MN, cytotoxicity and ROS formation with H2O2 and menadione exposure, but not with KBrO3. This implies a unique mechanism of action for KBrO3 induced genotoxicity. Chronic dosing in vitro may be a valuable approach allowing better understanding of how chemicals damage DNA and pose human hazards.
Identifiants
pubmed: 33259605
pii: 6015768
doi: 10.1093/mutage/geaa024
doi:
Substances chimiques
Mutagens
0
Oxidants
0
Reactive Oxygen Species
0
Tumor Suppressor Protein p53
0
Vitamin K 3
723JX6CXY5
Hydrogen Peroxide
BBX060AN9V
Glutathione
GAN16C9B8O
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
479-489Subventions
Organisme : National Centre for the Replacement, Refinement and Reduction of Animals in Research
ID : NC/R001375/1
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society.All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.